Literature DB >> 9288612

Antioxidant enzyme status in biliary obstructed rats: effects of N-acetylcysteine.

A Pastor1, P S Collado, M Almar, J González-Gallego.   

Abstract

BACKGROUND/AIMS: N-acetylcysteine (NAC) is a modulator of thiol levels that protects against hepatotoxic agents. The aim of this study was to investigate whether NAC might improve hepatic antioxidant defenses in chronically biliary obstructed rats.
METHODS: Secondary biliary cirrhosis was induced by 28 days of bile-duct obstruction. Groups of control and cirrhotic animals received NAC (50 mumol .kg-1.d-1 i.m.) through the experimental period.
RESULTS: Bile-duct obstruction resulted in decreased liver glutathione concentrations. Dichlorofluorescein (DCF) and thiobarbituric acid reactive substances (TBARS) concentrations, measured as markers of production of reactive oxygen species and lipid peroxidation, respectively, were significantly increased. Microsomal and mitochondrial membrane fluidity and the activities of catalase, cytosolic and mitochondrial superoxide dismutase (SOD), glutathione S-transferase, and cytosolic and mitochondrial Se-dependent and Se-independent glutathione peroxidase (GPx) were significantly reduced. NAC corrected the reduction in glutathione concentration and partially prevented the increases in DCF and TBARS concentrations. In addition, NAC treatment resulted in significant preservation of membrane fluidity and of the activities of catalase, mitochondrial SOD and the different forms of GPx.
CONCLUSIONS: Our data indicate that NAC maintains antioxidant defenses in biliary obstructed rats. These effects of NAC suggest that it may be a useful agent to preserve liver function in patients with biliary obstruction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9288612     DOI: 10.1016/s0168-8278(97)80183-3

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  33 in total

1.  Protective effects of thymoquinone against cholestatic oxidative stress and hepatic damage after biliary obstruction in rats.

Authors:  Serhat Oguz; Mehmet Kanter; Mustafa Erboga; Cengiz Erenoglu
Journal:  J Mol Histol       Date:  2012-01-21       Impact factor: 2.611

2.  NIM811 (N-methyl-4-isoleucine cyclosporine), a mitochondrial permeability transition inhibitor, attenuates cholestatic liver injury but not fibrosis in mice.

Authors:  Hasibur Rehman; Venkat K Ramshesh; Tom P Theruvath; Insil Kim; Robert T Currin; Shailendra Giri; John J Lemasters; Zhi Zhong
Journal:  J Pharmacol Exp Ther       Date:  2008-09-18       Impact factor: 4.030

3.  N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis.

Authors:  January N Baumgardner; Kartik Shankar; Leah Hennings; Emanuele Albano; Thomas M Badger; Martin J J Ronis
Journal:  J Nutr       Date:  2008-10       Impact factor: 4.798

4.  Hepatic damage in biliary-obstructed rats is ameliorated by leflunomide treatment.

Authors:  Abdurrahman Karaman; Mustafa Iraz; Hale Kirimlioglu; Nese Karadag; Erkan Tas; Ersin Fadillioglu
Journal:  Pediatr Surg Int       Date:  2006-08-05       Impact factor: 1.827

5.  The traditional ayurvedic medicine, Eugenia jambolana (Jamun fruit), decreases liver inflammation, injury and fibrosis during cholestasis.

Authors:  Ajay C Donepudi; Lauren M Aleksunes; Maureen V Driscoll; Navindra P Seeram; Angela L Slitt
Journal:  Liver Int       Date:  2011-12-30       Impact factor: 5.828

6.  Protective effect of low dose of melatonin against cholestatic oxidative stress after common bile duct ligation in rats.

Authors:  Mukaddes Esrefoglu; Mehmet Gül; Memet-Hanifi Emre; Alaattin Polat; Mukadder-Ayse Selimoglu
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

7.  Regulation of hepatic EAAT-2 glutamate transporter expression in human liver cholestasis.

Authors:  Mustapha Najimi; Xavier Stéphenne; Christine Sempoux; Etienne Sokal
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

8.  N-acetylcysteine attenuates oxidative stress and liver pathology in rats with non-alcoholic steatohepatitis.

Authors:  Duangporn Thong-Ngam; Suchittra Samuhasaneeto; Onanong Kulaputana; Naruemon Klaikeaw
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

9.  Cholestatic liver disease results increased production of reactive aldehydes and an atypical periportal hepatic antioxidant response.

Authors:  Colin T Shearn; Blair Fennimore; David J Orlicky; Yue R Gao; Laura M Saba; Kayla D Battista; Stefanos Aivazidis; Mohammed Assiri; Peter S Harris; Cole Michel; Gary F Merrill; Edward E Schmidt; Sean P Colgan; Dennis R Petersen
Journal:  Free Radic Biol Med       Date:  2019-08-01       Impact factor: 7.376

10.  Protective effect of Jasonia montana against ethinylestradiol-induced cholestasis in rats.

Authors:  Mohammed A Hussein; Soad M Abdel-Gawad
Journal:  Saudi Pharm J       Date:  2009-12-23       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.